Your browser doesn't support javascript.
loading
Pharmacodynamics, safety, and pharmacokinetics of BMS-663068, an oral HIV-1 attachment inhibitor in HIV-1-infected subjects.
Nettles, Richard E; Schürmann, Dirk; Zhu, Li; Stonier, Michele; Huang, Shu-Pang; Chang, Ih; Chien, Caly; Krystal, Mark; Wind-Rotolo, Megan; Ray, Neelanjana; Hanna, George J; Bertz, Richard; Grasela, Dennis.
Affiliation
  • Nettles RE; Research and Development, Bristol-Myers Squibb (BMS), Princeton, New Jersey 08534, USA.
J Infect Dis ; 206(7): 1002-11, 2012 Oct 01.
Article in En | MEDLINE | ID: mdl-22896665

Full text: 1 Database: MEDLINE Main subject: Organophosphates / Piperazines / HIV Infections / HIV-1 / HIV Fusion Inhibitors Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Infect Dis Year: 2012 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Organophosphates / Piperazines / HIV Infections / HIV-1 / HIV Fusion Inhibitors Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Infect Dis Year: 2012 Type: Article Affiliation country: United States